Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Recordati SpA

+ Add to Watchlist

RER1:GR

13.920 EUR 0.450 3.13%

As of 02:06:38 ET on 01/29/2015.

Snapshot for Recordati SpA (RER1)

Open: 14.370 Day's Range: 13.920 - 14.370 Volume: 0
Previous Close: 14.370 52wk Range: 10.825 - 14.440 1-Yr Rtn: +28.01%

Stock Chart for RER1

No chart data available.
  • RER1:GR 14.370
  • 1D
  • 1M
  • 1Y
14.370
Interactive RER1 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for RER1

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 18.3057
Relative P/E vs. DAX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) 0.7850
Est. PEG Ratio 2.6377
Market Cap (M EUR) 3,000.95
Shares Outstanding (M) 209.13
30 Day Average Volume 349
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 2.57%
Cash Dividend (EUR) 0.2600
Dividend Ex-Date 11/17/2014
5 Year Dividend Growth 8.16%
Next Earnings Announcement 03/04/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for RER1

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for RER1

Recordati S.p.A. manufactures pharmaceuticals. The Company researches,develops, manufactures, and markets prescription and non-prescription pharmaceuticals, pharmaceutical chemicals, therapeutic products and rare disease treatments. The Company sells its products throughout the world.

Giovanni RecordatiChairman/CEOAlberto RecordatiVice Chairman
Fritz SquindoManaging Director/CFOAndrea RecordatiChief Operating Officer
More Company Profile & Key Executives for RER1

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil